← Back to Search

PMP Integration & Nudge for Opioid Use Disorder (PRINCE Trial)

N/A

Recruiting

Led By Ezra Golberstein, PhD

Research Sponsored by University of Minnesota

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 months

Awards & highlights

PRINCE Trial Summary

This trial will test whether EHR-based decision support tools can nudge PCPs towards better pain treatment and opioid prescribing decisions, without forcing them.

Eligible Conditions

Opioid Use Disorder
Opioid Addiction

PRINCE Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Frequency of PDMP Checks

Secondary outcome measures

PCP Satisfaction #1

PCP Satisfaction #2

PCP Satisfaction #3

+4 more

PRINCE Trial Design

4Treatment groups

Experimental Treatment

Active Control

Group I: PMP Integration & NudgeExperimental Treatment1 Intervention

Clinics in this arm will receive the Prescription Drug Monitoring (PMP) Integration & Nudge intervention.

Group II: Choice Architecture Nudge + PMP Integration & NudgeExperimental Treatment2 Interventions

Clinics in this arm will receive both the choice architecture nudge and prescription drug monitoring (PMP) integration & nudge interventions.

Group III: Choice Architecture NudgeExperimental Treatment1 Intervention

Clinics in this arm will receive the choice architecture nudge intervention.

Group IV: Care as UsualActive Control1 Intervention

Clinics assigned to this arm will continue to care for the patients as usual in regards to opioid prescribing.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

PMP Integration & Nudge

2020

N/A

~1270

Choice Architecture Nudge

2020

N/A

~1270

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of MinnesotaLead Sponsor

1,378 Previous Clinical Trials

1,587,878 Total Patients Enrolled

National Institute on Drug Abuse (NIDA)NIH

2,465 Previous Clinical Trials

2,618,002 Total Patients Enrolled

Ezra Golberstein, PhDPrincipal InvestigatorUniversity of Minnesota

2 Previous Clinical Trials

1,262 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the cap for participants in this medical research project?

"Affirmative. Based on the data located at clinicaltrials.gov, this medical trial is actively recruiting participants as of 8/3/2022; it was initially posted to the site on 8/26/2020. The investigation requires 631 patients from a single research centre."

Answered by AI

Is enrollment currently open for this trial?

"As per clinicaltrials.gov, this trial is actively soliciting individuals for participation. It was originally published on August 26th 2020 with the latest revision taking place on August 3rd 2022."

Answered by AI